LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

Home・Listă Acțiuni・West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

Închisă

SectorSănătate

304.45 0.46

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

301.13

Maxim

307.45

Indicatori cheie
By Trading Economics
Venit	6.7M 139M
Vânzări	40M 845M
P/E Medie Sector	43.088 51.415
EPS	2.13
Randament dividend	0.26
Marjă de profit	16.428
Angajați	10,800
EBITDA	-36M 174M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+14.73% upside

Dividende
By Dow Jones
Randament dividend Medie Sector	0.26% 2.34%
Următoarele câștiguri	23 iul. 2026
Data viitoare de dividende	5 aug. 2026
Următoarea dată ex-dividende	29 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	2.7B 23B
Deschiderea anterioară	303.99
Închiderea anterioară	304.45

Sentimentul știrilor

By Acuity

100%

320 / 345 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

213.26 / 219.27 Suport & Rezistență

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

12 ian. 2026, 11:40 UTC

Achiziții, Fuziuni, Preluări

AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma

23 apr. 2026, 16:47 UTC

Câștiguri

This Pharma Stock Is Soaring After Earnings. It's a Sneaky GLP-1 Play. -- Barrons.com

12 ian. 2026, 11:02 UTC

Achiziții, Fuziuni, Preluări

AbbVie to Invest More Than $175 Million to Acquire, Modernize, Integrate Plant >ABBV WST

12 ian. 2026, 11:01 UTC

Achiziții, Fuziuni, Preluări

AbbVie Plans to Hire About 200 Employees at Acquired Site >ABBV WST

12 ian. 2026, 11:01 UTC

Achiziții, Fuziuni, Preluări

AbbVie To Buy Device Manufacturing Plant in Tempe, Ariz., Associated Intellectual Property From West >ABBV

12 ian. 2026, 11:00 UTC

Achiziții, Fuziuni, Preluări

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in U.S. >ABBV WST

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

14.73% sus

Prognoză pe 12 luni

Medie 347.5 USD 14.73%

Maxim 400 USD

Minim 310 USD

În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

7 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 7 analiști care au acordat evaluări ale acțiunilor West Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

320 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.